Resultados de la búsqueda 11-20 of 12139 for Apigenin

  1. Cáncer de próstata - Médicos y departamentos - Mayo Clinic

    707 4.293 8 8.9 ">Diag.707 43586 12.293 4.293 13.707 5.707 8 11.414z">&quodb0EAmp.707 4.293 8 8.586 12.293 4.293 lass="aem-GridColumn aem7"-iiiogo,umn aem- ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...

  4. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Rochester, Minn. The purposes of this study are to compare the functional connectivity in adolescent patients with Postural Orthostatic Tachycardia Syndrome ( ...

  5. Deficiencia de alfa-1 antitripsina

    Learn about alpha-1 antitrypsin deficiency. American Lung Association. https://www.lung.org/lung-health-diseases/lung-disease-lookup/alpha-1-antitrypsin- ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

  9. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...